key: cord-1000146-bohcydx9 authors: Singer, Pamela S.; Sethna, Christine; Molmenti, Ernesto; Fahmy, Ahmed; Grodstein, Elliot; Castellanos‐Reyes, Laura; Fassano, Jessica; Teperman, Lewis title: COVID‐19 infection in a pediatric kidney transplant population: A single‐center experience date: 2021-04-03 journal: Pediatr Transplant DOI: 10.1111/petr.14018 sha: 9fedf45913c087cf6f0bcb94dbc93a8e4ef0ce0d doc_id: 1000146 cord_uid: bohcydx9 BACKGROUND: The clinical course of SARS‐CoV‐2 in the pediatric kidney transplant population is not well described. METHODS: We performed a retrospective cohort study of a pediatric kidney transplant population at a New York transplant center. Baseline characteristics and clinical course of patients with SARS‐CoV‐2 positivity (Ab or PCR) were described, and comparison between COVID‐positive and COVID‐negative transplant patients was performed. RESULTS: Twenty‐two patients had COVID‐19 IgG testing performed, eight of whom also had PCR testing. 23% of our cohort had evidence of COVID‐19 infection. Four patients had positive IgG only, and one patient had a positive PCR. All five patients with a positive COVID test were female. Two patients had COVID‐19 symptoms, which were mild. Of the symptomatic patients, one had a positive PCR at time of symptoms, while the other had a negative PCR during symptoms but subsequently had positive IgG. As compared to patients with COVID‐19 negative results, those with COVID‐19 positivity were significantly more likely to have a known COVID‐19 exposure, and were also more likely to be female. There was no significant difference in time from transplant between the groups. Those in the COVID‐positive group had higher baseline antimetabolite dose and CNI troughs, although these did not reach statistical significance. CONCLUSIONS: Pediatric kidney transplant recipients are at risk for development of COVID‐19 infection. While this population may be more at risk for SARS‐CoV‐2 infection due to their immunosuppressed status, their clinical course appears mild and similar to a healthy pediatric population. An Italian study reported that approximately 75% of pediatric cases of SARS-CoV-2 were asymptomatic or mild. 3 However, it has been noted that chronically ill children may have a more severe course of disease. 6 Within the adult population, immunocompromised individuals including solid organ transplant recipients have been shown to be at high risk. [7] [8] [9] [10] [11] A multicenter study with over 100 adult kidney transplant recipients showed a mortality of 32%. 9 However, little is published on pediatric transplant recipients, and it is unknown whether their course of disease is more similar to adult transplant patients or to a healthy age-matched population. Here, we report our data on COVID-19 in pediatric kidney transplant recipients in a New York transplant center. We performed a single-center cohort study of pediatric kidney transplant recipients. From May 2017 to May 2020, we performed a total of 24 pediatric kidney transplants. Participants were patients ≤21 years at the Steven and Alexandra Cohen Children's Medical Center (CCMC), a part of Northwell Health, located on the border of Queens and Nassau counties in New York. All pediatric kidney transplant recipients who obtained blood work between 5/1/2020 and 7/15/2020 had COVID-19 antibody (Ab) testing performed as part of routine clinical care in order to help guide immunosuppressive management strategies and anticipatory guidance for patients. In addition, patients with symptoms concerning for SARS-CoV-2 infection (fever and/or respiratory symptoms) were evaluated with real-time polymerase chain reaction assay (PCR). Finally, patients who were admitted to the hospital or CCMC emergency room (ER), or who underwent any surgical procedures, obtained a COVID-19 screening PCR with or without Ab testing as part of current routine hospital protocol. Data were collected from the enterprise electronic health record (EHR; Sunrise Clinical Manager, Allscripts). COVID-19 positivity was defined as a positive result on nasopharyngeal swab using one of several nucleic acid amplification assays utilized at Northwell Health, and/or positive serum COVID-19 IgG result. tightness and one with fever, abdominal pain and muscle aches) and the remainder had testing done in conjunction with a hospital or ER admission or as part of pre-surgical testing. A total of five patients had positive COVID-19 results on either PCR or Ab testing. One patient was positive on PCR, performed due to clinical symptoms, and the remaining four were positive only on IgG testing. Of these four, one patient had two negative COVID PCRs in the setting of fever, abdominal pain and muscle pain, however subsequent IgG testing was positive. It is likely that her PCR results were false negatives, although it is possible that she had a separate asymptomatic infection, and that her COVID-like symptoms were due to another cause. Demographics of patients with positive COVID results are presented in Table 1 . COVID-related information on these patients is presented in Table were also more likely to be female. There was no significant difference in age, race, or blood type between the groups. Those in the COVID-positive group had higher baseline antimetabolite dose and CNI troughs, although these did not reach statistical significance. Table 3 shows comparative data between the COVID-positive and COVID-negative groups. Transplant Recipients COVID Our results found that 18% of the tested pediatric kidney trans- Although this is a small, single-center study, our COVID prevalence is similar to that reported in May through the New York State Ab testing study, which found 11.9% seropositivity in Long Island and 19.9% in New York City in a study population of 15,000 individuals. 14 However, age-specific rates are not available, and it is possible that our population has a higher prevalence than healthy age-matched controls. needed to assess for chronic or later-developing complications. The authors declare no conflict of interest. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)-United States Clinical features of pediatric patients with coronavirus disease (COVID-19) Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention SARS-CoV-2 infection in children Early Experience of COVID-19 in a US children' hospital COVID-19 in solid organ transplant recipients: Initial report from the US epicenter COVID-19 in solid organ transplant recipients: a single-center case series from Spain COVID-19 and kidney transplantation: results from the TANGO international transplant consortium Early experience with COVID-19 and solid organ transplantation at a US high-volume transplant center COVID-19 in kidney transplant recipients Failed antibody response in a kidneytransplant recipient with SARS-CoV-2 infected Influence of immunosuppression on seroconversion against SARS-CoV-2 in two kidney transplant recipients COVID-19 infection in kidney transplant recipients: disease incidence and clinical outcomes Blood type A associates with critical COVID-19 and death in a Swedish cohort Association between ABO blood groups and COVID-19 infection, severity and demise: a systematic review and meta-analysis Multisystem inflammatory syndrome in U.S. children and adolescents Hyperinflammatory shock in children during COVID-19 pandemic How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management COVID-19 in immunocompromised hosts: what we know so far Multisystem inflammatory syndrome in children: a systematic review Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2